Therefore, in the future, the regulatory mechanisms operating between nonalcoholic fatty liver disease (NAFL) and nonalcoholic steatohepatitis (NASH) and TRPM4 should be comprehensively explored to gain a complete understanding of NAFLD pathophysiology. Here, TRPM4 is linked to metabolic dysfunction-associated steatohepatitis.